{"pmid":32382126,"pmcid":"PMC7203722","title":"Protective humoral immunity in SARS-CoV-2 infected pediatric patients.","text":["Protective humoral immunity in SARS-CoV-2 infected pediatric patients.","Cell Mol Immunol","Zhang, Yaguang","Xu, Jin","Jia, Ran","Yi, Chunyan","Gu, Wangpeng","Liu, Pengcheng","Dong, Xinran","Zhou, Hao","Shang, Bo","Cheng, Shipeng","Sun, Xiaoyu","Ye, Jing","Li, Xuezhen","Zhang, Jia","Ling, Zhiyang","Ma, Liyan","Wu, Bingbing","Zeng, Mei","Zhou, Wenhao","Sun, Bing","32382126"],"journal":"Cell Mol Immunol","authors":["Zhang, Yaguang","Xu, Jin","Jia, Ran","Yi, Chunyan","Gu, Wangpeng","Liu, Pengcheng","Dong, Xinran","Zhou, Hao","Shang, Bo","Cheng, Shipeng","Sun, Xiaoyu","Ye, Jing","Li, Xuezhen","Zhang, Jia","Ling, Zhiyang","Ma, Liyan","Wu, Bingbing","Zeng, Mei","Zhou, Wenhao","Sun, Bing"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32382126","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1038/s41423-020-0438-3","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666419683332456449,"score":9.490897,"similar":[{"pmid":32430094,"title":"The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.","text":["The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.","SARS-CoV-2 is a novel coronavirus that is the causative agent of coronavirus infectious disease 2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in 145 144 deaths. The timing, magnitude and longevity of humoral immunity is not yet understood for SARS-CoV-2. Nevertheless, understanding this is urgently required to inform the likely future dynamics of the pandemic, to guide strategies to allow relaxation of social distancing measures and to understand how to deploy limiting vaccine doses when they become available to achieve maximum impact. SARS-CoV-2 is the seventh human coronavirus to be described. Four human coronaviruses circulate seasonally and cause common colds. Two other coronaviruses, SARS and MERS, have crossed from animal sources into humans but have not become endemic. Here we review what is known about the human humoral immune response to epidemic SARS CoV and MERS CoV and to the seasonal, endemic coronaviruses. Then we summarize recent, mostly non-peer reviewed, studies into SARS-CoV-2 serology and reinfection in humans and non-human primates and summarize current pressing research needs.","J Gen Virol","Kellam, Paul","Barclay, Wendy","32430094"],"abstract":["SARS-CoV-2 is a novel coronavirus that is the causative agent of coronavirus infectious disease 2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in 145 144 deaths. The timing, magnitude and longevity of humoral immunity is not yet understood for SARS-CoV-2. Nevertheless, understanding this is urgently required to inform the likely future dynamics of the pandemic, to guide strategies to allow relaxation of social distancing measures and to understand how to deploy limiting vaccine doses when they become available to achieve maximum impact. SARS-CoV-2 is the seventh human coronavirus to be described. Four human coronaviruses circulate seasonally and cause common colds. Two other coronaviruses, SARS and MERS, have crossed from animal sources into humans but have not become endemic. Here we review what is known about the human humoral immune response to epidemic SARS CoV and MERS CoV and to the seasonal, endemic coronaviruses. Then we summarize recent, mostly non-peer reviewed, studies into SARS-CoV-2 serology and reinfection in humans and non-human primates and summarize current pressing research needs."],"journal":"J Gen Virol","authors":["Kellam, Paul","Barclay, Wendy"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32430094","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1099/jgv.0.001439","keywords":["covid-19","sars-cov-2","antibodies","reinfection","serology"],"topics":["Mechanism"],"weight":1,"_version_":1667342288120971264,"score":54.05192},{"pmid":32413330,"pmcid":"PMC7196424","title":"Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.","text":["Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.","The World Health Organization has declared SARS-CoV-2 virus outbreak a worldwide pandemic. However, there is very limited understanding on the immune responses, especially adaptive immune responses to SARS-CoV-2 infection. Here, we collected blood from COVID-19 patients who have recently become virus-free, and therefore were discharged, and detected SARS-CoV-2-specific humoral and cellular immunity in eight newly discharged patients. Follow-up analysis on another cohort of six patients 2 weeks post discharge also revealed high titers of immunoglobulin G (IgG) antibodies. In all 14 patients tested, 13 displayed serum-neutralizing activities in a pseudotype entry assay. Notably, there was a strong correlation between neutralization antibody titers and the numbers of virus-specific T cells. Our work provides a basis for further analysis of protective immunity to SARS-CoV-2, and understanding the pathogenesis of COVID-19, especially in the severe cases. It also has implications in developing an effective vaccine to SARS-CoV-2 infection.","Immunity","Ni, Ling","Ye, Fang","Cheng, Meng-Li","Feng, Yu","Deng, Yong-Qiang","Zhao, Hui","Wei, Peng","Ge, Jiwan","Gou, Mengting","Li, Xiaoli","Sun, Lin","Cao, Tianshu","Wang, Pengzhi","Zhou, Chao","Zhang, Rongrong","Liang, Peng","Guo, Han","Wang, Xinquan","Qin, Cheng-Feng","Chen, Fang","Dong, Chen","32413330"],"abstract":["The World Health Organization has declared SARS-CoV-2 virus outbreak a worldwide pandemic. However, there is very limited understanding on the immune responses, especially adaptive immune responses to SARS-CoV-2 infection. Here, we collected blood from COVID-19 patients who have recently become virus-free, and therefore were discharged, and detected SARS-CoV-2-specific humoral and cellular immunity in eight newly discharged patients. Follow-up analysis on another cohort of six patients 2 weeks post discharge also revealed high titers of immunoglobulin G (IgG) antibodies. In all 14 patients tested, 13 displayed serum-neutralizing activities in a pseudotype entry assay. Notably, there was a strong correlation between neutralization antibody titers and the numbers of virus-specific T cells. Our work provides a basis for further analysis of protective immunity to SARS-CoV-2, and understanding the pathogenesis of COVID-19, especially in the severe cases. It also has implications in developing an effective vaccine to SARS-CoV-2 infection."],"journal":"Immunity","authors":["Ni, Ling","Ye, Fang","Cheng, Meng-Li","Feng, Yu","Deng, Yong-Qiang","Zhao, Hui","Wei, Peng","Ge, Jiwan","Gou, Mengting","Li, Xiaoli","Sun, Lin","Cao, Tianshu","Wang, Pengzhi","Zhou, Chao","Zhang, Rongrong","Liang, Peng","Guo, Han","Wang, Xinquan","Qin, Cheng-Feng","Chen, Fang","Dong, Chen"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32413330","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.immuni.2020.04.023","keywords":["covid-19 patients","sars-cov-2","sars-cov-2-specific t cells","sars-cov-2-specific antibody","adaptive immunity"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666989866125099008,"score":45.43823},{"pmid":32405102,"pmcid":"PMC7218368","title":"A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection.","text":["A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection.","SARS-CoV-2 infection displays immense inter-individual clinical variability, ranging from silent infection to lethal disease. The role of human genetics in determining clinical response to the virus remains unclear. Studies of outliers - individuals remaining uninfected despite viral exposure and healthy young patients with life-threatening disease - presents a unique opportunity to reveal human genetic determinants of infection and disease.","Cell","Casanova, Jean-Laurent","Su, Helen C","32405102"],"abstract":["SARS-CoV-2 infection displays immense inter-individual clinical variability, ranging from silent infection to lethal disease. The role of human genetics in determining clinical response to the virus remains unclear. Studies of outliers - individuals remaining uninfected despite viral exposure and healthy young patients with life-threatening disease - presents a unique opportunity to reveal human genetic determinants of infection and disease."],"journal":"Cell","authors":["Casanova, Jean-Laurent","Su, Helen C"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405102","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.cell.2020.05.016","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666802845545922560,"score":40.380013}]}